Remove tag infants
article thumbnail

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Rethinking Clinical Trials

The Parent-Focused Redesign for Encounters, Newborns to Toddlers (PARENT) study was a randomized controlled trial of PARENT verses usual care for parents with infants 12 months and younger over a 12-month study period. Adapted for early childhood preventive care, the structure should be team- and community-based.

Trials 269
article thumbnail

Grand Rounds February 3, 2023: Pragmatic Trials For Children With Congenital Heart Disease – Insights From The NITRIC Trial (Luregn Schlapbach, PhD, FCICM)

Rethinking Clinical Trials

All infants and children less than 2 years of age undergoing open heart surgery on cardiopulmonary bypass were eligible for the study with exclusions for diseases that implied high severity pre-bypass. . – Why didn’t you start to design the follow-on trial while you were still in the field?

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis’ $2 Million Gene Therapy Zolgensma Shows ‘Remarkable’ Results and Offers Hope for Children with SMA

XTalks

With a price tag of over $2.5 They also advised use of Zolgensma for infants with SMA type 1 before they develop symptoms. Participants included symptomatic infants with SMA type I who had two copies of SMN2 who received prior treatment with low IV doses of Zolgensma in the trial. Why is Zolgensma So Expensive?

article thumbnail

Calamine lotion for chickenpox skin itchiness

Druggist

Despite its higher price tag as compared with other products sold for the management of chickenpox PoxClin Cool Mousse is regarded as ‘highly-rated’ and well-priced product on Amazon.co.uk E45 Itch Relief Cream can be used in children and infants over the age of one month. Buy on Amazon Price incl. Buy on Amazon Price incl.

article thumbnail

Roche takes on pricey rivals as FDA approves SMA drug

pharmaphorum

While this is not cheap by anybody’s reckoning, Roche hopes that the less intimidating price tag, plus the patient-friendly oral administration method will give it a competitive edge. Infants achieved the ability to sit without support for at least five seconds, a key motor milestone not normally seen in the natural course of the disease.